The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, elevated levels of high density lipoprotein cholesterol reduces the risk of arteriosclerosis (42,43).”
From Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* (2010) · cites this paper as [43]
Citations
Cites
Cholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314
Self-citationThe Pooling Project Research Group (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90073-5 · Cited by 994
Lipoproteins, Cardiovascular Disease, and Death
Gordon, T. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090024008 · Cited by 565
Cited by
Sorted by citations
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
“gif" NDATA ITEM> ]> Introduction Epidemiological studies have demonstrated that plasma HDL-C concentration is inversely related to the incidence of coronary artery diseas”
BackgroundMetabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
Kannel, W. B. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90511-4 · Cited by 459
Self-citationExpression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation*
Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I. A., MacDougald, O. A., & Bommer, G. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.152090 · Cited by 382
Grainger, D. J., Kemp, P. R., Metcalfe, J. C., Liu, A. C., Lawn, R. M., Williams, N. R., Grace, A. A., Schofield, P. M., & Chauhan, A. (1995) · Nature Medicine · doi:10.1038/nm0195-74 · Cited by 377
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336
“The atherogenic component of serum total-C derives from the LDL-C fraction, and the HDL-C component was shown to be inversely related to the development of CHD.39,40 Although the strength of the relation of total-C to CHD declines after 60 years of age in men, the totalC/HDL-C ratio continues to predict events reliabl…”
Background
Metadata
- Authors
- Kannel, W. B.
- Affiliations
- Boston University (US)
- Corresponding author
- Kannel, William B.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1983-08
- Volume
- 52
- Issue
- 4
- Pages
- B9-B12
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2084240983
- Cited by
- 242
- References
- 3
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 12
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- high-density lipoprotein, HDL cholesterol, coronary artery disease, LDL cholesterol, LDL/HDL ratio, total cholesterol, atherogenesis, lipoprotein subfractions, apolipoproteins, stroke, peripheral arterial disease, colon cancer, cardiovascular risk
- MeSH terms
- Cholesterol, Coronary Disease, Humans, Lipoproteins, HDL, Cholesterol, HDL, Lipoproteins, LDL, Cholesterol, LDL, Lipoproteins, VLDL, Risk, Triglycerides, Cholesterol, VLDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
